Lanthanum acetate inhibits vascular calcification induced by vitamin D3 plus nicotine in rats

Experimental Biology and Medicine

Volumn 234, Issue 8, 2009, Pages 908-917

  Zhou, Ye Bo ^a   Jin, Shao Ju ^b   Cai, Yan ^a   Teng, Xu ^a   Chen, Li ^c   Tang, Chao Shu ^a,c   Qi, Yong Fen ^a,c,d  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Lanthanum acetate; Matrix Gla protein; Type III sodium dependent phosphate cotransporter Pit 1; Vascular calcification

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; COLECALCIFEROL; LANTHANUM; LANTHANUM ACETATE; NICOTINE; OSTEOCALCIN; OSTEOPONTIN; PHOSPHORUS; TRANSCRIPTION FACTOR PIT 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL CALCIFICATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; ELASTIC FIBER; ENZYME ACTIVITY; IN VIVO STUDY; MALE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ACETATES; ANIMALS; AORTA; CALCINOSIS; CALCIUM; CALCIUM-BINDING PROTEINS; CHOLECALCIFEROL; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; LANTHANUM; MALE; NICOTINE; OSTEOPONTIN; PHOSPHORUS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III;

RATTUS;

EID: 68149144393     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0811-RM-346     Document Type: Article

References (40)

1. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99:1044-1059, 2006.
2. Demer LL, Tintut Y. Mineral exploration: search for the mechanism of vascular calcification and beyond: the 2003 Jeffrey M. Hoeg Award lecture. Arterioscler Thromb Vasc Biol 23:1739-1743, 2003.
3. Huitema LF, Vaandrager AB. What triggers cell-mediated mineralization? Front Biosci 12:2631-2645, 2007.
4. Simionescu A, Philips K, Vyavahare N. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun 334:524-532, 2005.
5. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:10-17, 2000.
6. Mackey RH, Kuller LH, Sutton-Tyrrell K, Evans RW, Holubkov R, Matthews KA. Hormone therapy, lipoprotein subclasses, and coronary calcification: The Healthy Women Study. Arch Intern Med 165:510-515, 2005.
7. Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis 185:394-399, 2006.
8. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E. J Am Coll Cardiol 46:166-172, 2005.
9. Boonen S, Vanderschueren D, Venken K, Milisen K, Delforge M, Haentjens P. Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance. J Intern Med 264:315-332, 2008.
10. Shimshi M, Abe E, Fisher EA, Zaidi M, Fallon JT. Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice. Biochem Biophys Res Commun 328:790-793, 2005.
11. Das T, Sharma A, Talukder G. Effects of lanthanum in cellular systems. Biol Trace Elem Res 18:201-228, 1988.
12. Weiss GB, Goodman FR. Effects of lanthanum on contraction, calcium distribution and Ca45 movements in intestinal smooth muscle. J Pharmacol Exp Ther 169:46-55, 1969.
13. Tsien RW, Hess P, McCleskey EW, Rosenberg RL. Calcium channels: mechanism of selectivity, proliferation and block. Annu Rev Biophys Chem 16:265-290, 1987.
14. Van Breemen C, Farinas B, Gerba P, McNaughton E. Excitation-Contraction coupling in rabbit aorta studied by the lanthanum method for measuring cellular calcium influx. Circ Res 30:44-54, 1972.
15. Shigematsu T. Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis. Ther Apher Dial 12:55-61, 2008.
16. Hutchison AJ, Barnett ME, Krause R, Kwan JT, Siami GA. Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment. Nephron Clin Pract 110:15-23, 2008.
17. Sprague SM. A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate. Curr Med Res Opin 23:3167-3175, 2007.
18. Kaygisiz Z, Akin MZ, Basaran A, Günes HV, Timuralp B. The effect of lanthanum on the mechanical function of the isolated perfused rat heart at different extracellular calcium concentrations. Acta Physiol Hung 78:191-200, 1991.
19. Gillies PJ, Robinson CS, Cockrell BY, Jay Graepel G. Effect of lanthanum chloride on established atherosclerosis in the cholesterol-fed rabbit mitral valve as a site for assessment of treatment effects. Arteriosclerosis 9:253-260, 1989.
20. Shi Y, Gou BD, Shi YL, Zhang TL, Wang K. Lanthanum chloride suppresses hydrogen peroxide-enhanced calcification in rat calcifying vascular cells. Biometals [Epub ahead of print], 2008.
21. Wu SY, Zhang BH, Pan CS, Jiang HF, Pang YZ, Tang CS, Qi YF. Endothelin-1 is a potent regulator in vivo in vascular calcification and in vitro in calcification of vascular smooth muscle cells. Peptides 24:1149-1156, 2003.
22. Wu SY, Pan CS, Geng B, Zhao J, Yu F, Pang YZ, Tang CS, Qi YF. Hydrogen sulfide ameliorates vascular calcification induced by vitamin D3 plus nicotine in rats. Acta Pharmacol Sin 27:299-306, 2006.
23. Qi YF, Wang SH, Zhang BH, Bu DF, Tang CS, Du JB. Changes of amount of ADM mRNA and RAMP2 mRNA in calcified vascular smooth muscle cells. Peptides 24:287-294, 2003.
24. Chen PS, Toribara TY, Huber W. Microdetermination of phosphorus. Anal Chem 28:1756-1758, 1956.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976.
26. Qi YF, Bu DF, Niu da D, Shi YR, Wang SH, Pang YZ, Tang CS, Du JB. Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene. Peptides 23:1141-1147, 2002.
27. Jegger D, da Silva R, Jeanrenaud X, Nasratullah M, Tevaearai H, von Segesser LK, Segers P, Gaillard V, Atkinson J, Lartaud I, et al. Ventricular-arterial coupling in a rat model of reduced arterial compliance provoked by hypervitaminosis D and nicotine. Am J Physiol Heart Circ Physiol 291:H1942-1951, 2006.
28. Rajasree S, Umashankar PR, Lal AV, Sarma PS, Kartha CC. 1,25-dihydroxyvitamin D3 receptor is upregulated in aortic smooth muscle cells during hypervitaminosis D. Life Sci 70:1777-1788, 2002.
29. Kilaru S, Frangos SG, Chen AH, Gortler D, Dhadwal AK, Araim O, Sumpio BE. Nicotine: a review of its role in atherosclerosis. J Am Coll Surg 193:538-546, 2001.
30. Zhou J, Olson BL, Windsor LJ. Nicotine increases the collagen-degrading ability of human gingival fibroblasts. J Periodont Res 42:228-235, 2007.
31. 2+ exchange. Ann N Y Acad Sci 779:546-550, 1996.
32. Raval J, Joshua IG, Webb Clinton R, Bohr DF. Lanthanum potentiation of the vascular response to a protein kinase C activator in genetically hypertensive rats. J Hypertens Suppl 7:146-147, 1989.
33. Gulyaev SM, Ubasheev IO, Kozhevnikova NM. Morphological assessment of the cerebroprotective action of lanthanum acetate in chronic cerebral ischemia in rats. Neurosci Behav Physiol 38:747-750, 2008.
34. Son BK, Akishita M, Iijima K, Eto M, Ouchi Y. Mechanism of piinduced vascular calcification. J Atheroscler Thromb 15:63-68, 2008.
35. Ewence AE, Bootman M, Roderick HL, Skepper JN, McCarthy G, Epple M, Neumann M, Shanahan CM, Proudfoot D. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ Res 103:E28-34, 2008.
36. Iyemere VP, Proudfoot D, Weissberg PL, Shanahan CM. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 260:192-210, 2006.
37. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98:905-912, 2006.
38. Schurgers LJ, Cranenburg EC, Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost 100:593-603, 2008.
39. D'Haese PC, Spasovski GB, Sikole A, Hutchison A, Freemont TJ, Sulkova S, Swanepoel C, Pejanovic S, Djukanovic L, Balducci A, et al. Multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int Suppl 63:S73-78, 2003.
40. Behets GJ, Dams G, Vercauteren SR, Damment SJ, Bouillon R, De Broe ME, D'Haese PC. Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure? J Am Soc Nephrol 15:2219-2228, 2004.